Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
MannKind: Afrezza Sales Start Off 2017 Modestly. Will A Bigger Sales Force Make A Material Difference?
Seeking Alpha
Tue, 01/17/17 - 10:22 pm
MannKind
Afrezza
diabetes
drug reps
inhaled insulin
Novo Nordisk slumps 5.4% on U.S. price fixing lawsuit
Marketwatch
Thu, 01/12/17 - 09:16 am
Novo Nordisk
drug pricing
insulin
diabetes
price collusion
Physicians group urges metformin rather than new drugs
Medical Marketing and Media
Thu, 01/12/17 - 09:15 am
metformin
diabetes
American College of Physicians
generics
MannKind's $1M Milestone: Good News, But Barely
Seeking Alpha
Wed, 01/4/17 - 10:41 am
MannKind
diabetes
Receptor Life Sciences
Mannkind's Afrezza Is Fizzling Out
Seeking Alpha
Mon, 01/2/17 - 11:58 am
MannKind
Afrezza
diabetes
inhaled insulin
Merck Continues to Dominate with Its Januvia Franchise
Market Realist
Thu, 12/29/16 - 10:04 am
Merck
Januvia
diabetes
Sanofi sues Novo over 'misleading' Tresiba marketing materials
Fierce Pharma
Wed, 12/28/16 - 11:21 am
Sanofi
Novo Nordisk
Tresiba
diabetes
Once-promising diabetes ‘breakthrough’ comes unglued with a major retraction
Stat
Wed, 12/28/16 - 11:09 am
diabetes
stem cells
Regeneron
ADA guidelines highlight new Jardiance label
BioPharma Dive
Mon, 12/19/16 - 11:39 am
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
Victoza
Lilly, Boehringer’s Basaglar long-acting insulin now available in the U.S.
Mass Device
Thu, 12/15/16 - 06:41 pm
Eli Lilly
Boehringer Ingelheim
Basaglar
insulin
diabetes
long-acting insulin
FDA Clears New Tool for Patients with Type 2 Diabetes
Qmed
Thu, 12/15/16 - 10:18 am
diabetes
FDA
JNJ
type 2 diabetes
LifeScan
blood glucose monitoring
WellDoc
Lilly to offer insulin at discounted prices
Yahoo/Reuters
Tue, 12/13/16 - 10:16 am
Eli Lilly
diabetes
insulin
Blink Health
Novo Nordisk: Why The Diabetes Giant Will Continue To Grow
Seeking Alpha
Tue, 12/13/16 - 10:14 am
Novo Nordisk
diabetes
Tresiba
Saxenda
Victoza
Sanofi to cut US diabetes staff
BioPharma Dive
Sat, 12/10/16 - 10:33 am
Sanofi
layoffs
diabetes
drug reps
BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
Medical Marketing and Media
Tue, 12/6/16 - 10:05 pm
Boehringer Ingelheim
Eli Lilly
cardiologists
diabetes
Jardiance
Nordisk touts Tresiba insulin injection data
Drug Delivery Business
Thu, 12/1/16 - 09:51 am
Novo Nordisk
Tresiba
insulin
diabetes
insulin injection
2 Key Reasons MannKind Needs To Remain On Nasdaq
Seeking Alpha
Wed, 11/30/16 - 09:57 am
MannKind
diabetes
NASDAQ
Afrezza
MannKind - Afrezza Scripts Still Low As Year-End Holidays Approach
Seeking Alpha
Mon, 11/28/16 - 11:40 pm
MannKind
Afrezza
diabetes
inhaled insulin
Novo Nordisk’s Diabetes Drug Gets FDA OK
Investopedia
Tue, 11/22/16 - 09:53 pm
Novo Nordisk
FDA
diabetes
Xultophy
Sanofi Gets FDA OK for Diabetes Drug Soliqua
Investopedia
Tue, 11/22/16 - 09:47 pm
Sanofi
FDA
Soliqua
diabetes
Pages
« first
‹ previous
…
36
37
38
39
40
41
42
43
44
…
next ›
last »